1 Min Read
April 5 (Reuters) - Co Don AG:
* CONCLUSION OF PHASE II TRIAL ‘CO.DIS’ DEMONSTRATES EFFICACY AND SAFETY OF EU-AUTHORISED PHARMACEUTICAL PRODUCT SPHEROX Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.